Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma

To evaluate the efficacy and safety of mitoxantrone Hydrochloride Hydrochloride Liposome combination regimen in the treatment of high-risk/extramedullary multiple myeloma

Trial Details

NCT ID
NCT06246162
Phase
PHASE1 / PHASE2
Sponsor
Affiliated Hospital of Nantong University
Status
RECRUITING
Cancer Type
Multiple Myeloma
Interventions
  • Lipo-MIT combination regimen
Locations (sample)
  • Nantong, Jiangsu, China|32.03028,120.87472

Key Eligibility Criteria

  • 1\. Diagnosed with high-risk multiple myeloma (del17p, t (4; 14), t (14; 16), 1q21 by FISH test) or extramedullary multiple myeloma; 2. Age: 18-70 …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Multiple Myeloma Trials on Trialify →